Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
US Market

Innovation Pharmaceuticals (IPIX) Financial Statements

131 Followers

Innovation Pharmaceuticals Financial Overview

Innovation Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.005; its P/E ratio is -1.96; Innovation Pharmaceuticals is scheduled to report earnings on May 10, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit---$ 14.00K-
EBIT$ -866.00K-$ -679.00K$ -305.00K$ -1.41M
EBITDA$ -772.00K-$ -586.00K$ -211.00K$ -1.32M
Net Income Common Stockholders$ -880.00K$ 2.07M$ -698.00K$ -319.00K$ -1.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 864.00K$ 1.52M$ 1.94M$ 2.42M$ 2.97M
Total Assets$ 6.67M$ 7.52M$ 7.99M$ 8.69M$ 9.34M
Total Debt$ 238.00K$ 268.00K$ 346.00K$ 393.00K$ 450.00K
Net Debt$ -626.00K$ -1.25M$ -1.59M$ -2.03M$ -2.52M
Total Liabilities$ 5.50M$ 5.48M$ 5.28M$ 5.61M$ 5.92M
Stockholders Equity$ 1.16M$ 2.04M$ 2.72M$ 3.08M$ 3.42M
Cash Flow-
Free Cash Flow$ -679.00K-$ -469.00K$ -477.00K$ -795.00K
Operating Cash Flow$ -677.00K$ -369.00K$ -469.00K$ -477.00K$ -791.00K
Investing Cash Flow$ -2.00K$ -12.00K$ -17.00K$ -27.00K$ -4.00K
Financing Cash Flow$ 25.00K$ -41.00K$ 3.00K$ -41.00K$ -44.00K
Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

Innovation Pharmaceuticals Debt to Assets

Innovation Pharmaceuticals Cash Flow

Innovation Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis